Immunome (IMNM) Non-Current Deffered Revenue (2019 - 2024)
Immunome's (IMNM) quarterly Non-Current Deffered Revenue came in at $2.2 million in Q1 2024, down 76.56% YoY from $9.4 million in Q2 2023, and down 59.77% on a QoQ basis from $5.5 million in Q4 2023.
Immunome (IMNM) Non-Current Deffered Revenue (2019 - 2024) Analysis & Trends
Immunome (IMNM) has 5 years of Non-Current Deffered Revenue data on file, last reported at $2.2 million in Q1 2024.
- Quarterly Non-Current Deffered Revenue fell 76.56% year-over-year to $2.2 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $2.2 million (down 76.56% YoY) and the FY2023 annual result came in at $5.5 million, changed N/A from the prior year.
- Non-Current Deffered Revenue slipped to $2.2 million in Q1 2024, from $5.5 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $9.4 million in Q1 2023 to a low of $3000.0 in Q2 2021.
- A 4-year average of $2.3 million and a median of $12000.0 in 2021 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2021 — Non-Current Deffered Revenue jumped 50.0% — and 2024, when it tumbled 76.56%.
- Tracing IMNM's Non-Current Deffered Revenue over 4 years: stood at $8000.0 in 2020, then jumped by 50.0% to $12000.0 in 2021, then soared by 45641.67% to $5.5 million in 2023, then tumbled by 59.77% to $2.2 million in 2024.
- The last three Non-Current Deffered Revenue figures came in at $2.2 million (Q1 2024), $5.5 million (Q4 2023), and $2.9 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immunome | 3.09 Bn | 2.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2.21 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Sep 30, 2023 | 2.85 Mn |
| Jun 30, 2023 | 5.71 Mn |
| Mar 31, 2023 | 9.42 Mn |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 5,000.00 |
| Dec 31, 2020 | 8,000.00 |
| Sep 30, 2020 | 11,000.00 |
| Dec 31, 2019 | 18,000.00 |